Tag Archives: Pfizer

Pfizer Ends Sutent Trial

By Jennifer Ringler | Published: September 29, 2010
Successful cancer drug Sutent may not be effective in prolonging life for patients with castration-resistant prostate cancer. This week, Pfizer announced that it has ended a Phase III trial of cancer drug Sutent. The drug, which was being tested as a treatment for patients with prostate cancer, has already been approved as a treatment for kidney [...]
Posted in News | Also tagged , | 1 Comment

Pfizer and American Kennel Club Team Up For New Research

By Jeff Schindler | Published: September 8, 2010
Pfizer’s Animal Health unit has signed an exclusive deal with the American Kennel Club’s Canine Health Foundation (CHF)—the largest nonprofit worldwide—to fund health research exclusively for canines. This new research partnership names Pfizer Animal Health the sole biopharmaceutical partner of CHF, and begins with Pfizer committing to provide an initial $50,000 over a two-year period. According to [...]
Posted in Deals | Also tagged | Leave a comment

Pfizer Adds FoldRx to its Specialty Care Unit

By George Koroneos | Published: September 1, 2010
Pfizer on Wednesday announced that it acquired a small rare-disease drug firm, FoldRx, for an undisclosed sum of money. Pfizer spokeswoman Gwen Fischer told Pharm Exec that the deal came together in a matter of weeks, and that FoldRx will be fully incorporated into Pfizer’s research division. All of FoldRx’s employees are expected to become Pfizer [...]
Posted in Deals, Strategy | Also tagged , | Leave a comment

GSK Scores High in Market Access

By George Koroneos | Published: June 23, 2010
GlaxoSmithKline ranked number one in a study of pharmaceutical companies offering access to medicines to emerging and developing nations, proving that the UK drug giant has a far stronger grasp on new markets than its US and Japanese counterparts. The study ranks 20 companies based on significant criteria including pricing, patents and intellectual properties, capacity enhancement, [...]
Posted in Emerging Markets, Strategy | Also tagged , , , , , , | Leave a comment

Pharma Digital Smarts Quantified in IQ Index

By Julian Upton | Published: May 26, 2010
Pfizer’s Viagra and AstraZeneca’s (AZ) Nexium took the top two slots on a new Digital IQ Index measuring the digital competence of 51 pharma brands across eight therapeutic categories. The ranking, created by think tank L2 in partnership with media agency PHD Network, evaluated brands’ digital presence across four criteria: platform (including site effectiveness and [...]
Posted in E-Media | Also tagged , , , , , , , , | 1 Comment